TRLS.L
Trellus Health plc [TRLS.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
TRLS.L Stock Summary
In the News
TRLS.L Financial details
Company Rating
-
Market Cap
3.07M
Income
-7.54M
Revenue
22K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
31
Optionable
No
Shortable
Yes
Earnings
21 May 2024
P/E
-1.26
Forward P/E
-
PEG
-3.14
P/S
616.8
P/B
0.44
P/C
-
P/FCF
-0.96
Quick Ratio
23.22
Current Ratio
23.56
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.05
EPS next Y
-
EPS next Q
-
EPS this Y
21.65%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-3.37%
SMA50
-18.48%
SMA100
164.62%
Inst Own
-
Inst Trans
-
ROA
-34%
ROE
-29%
ROC
-0.35%
Gross Margin
100%
Oper. Margin
-48944%
Profit Margin
-48944%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.85-9.65
52W High
-79.44%
52W Low
+85%
RSI
53.41
Rel Volume
8.06
Avg Volume
170.32K
Volume
1.37M
Perf Week
2.78%
Perf Month
-2.63%
Perf Quarter
174.07%
Perf Half Y
174.07%
-
-
-
-
Beta
0.102
-
-
Volatility
0.07%, 0.13%
Prev Close
12.12%
Price
1.85
Change
9.47%
Company Profile
- Volume Average 170.32K
- Market Capitalization 3.07M
- Employee 31
- CEO Dr. Marla Cindy Dubinsky M.D.
- Headquarters White Plains,NY,US
- IPO Date 2021-05-31
-
Website
https://www.trellushealth.com 
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The company was founded in 2020 and is headquartered in White Plains, New York.
